Click here to take the CME Evaluation and Post-Meeting Survey
Dr. Rosalyn Plotzker is an assistant professor in the UCSF Department of Epidemiology and Biostatistics. Rosalyn completed a fellowship in Sexually Transmitted Diseases at UCSF and the California Department of Public Health where she currently serves as a public health medical officer and clinical lead for congenital syphilis prevention and response. She also serves as clinical faculty for the California Prevention Training Center (CAPTC), which is funded by the Centers for Disease Control and Prevention to educate providers on best practices in STI diagnosis and treatment. Finally, Rosalyn performs high resolution anoscopy at the UCSF Anal Neoplasia Clinic, Research and Education (ANCRE) Center and is a member of the International Anal Neoplasia Society (IANS) task force on anal cancer screening guidelines. Rosalyn earned her BA from the University of Pennsylvania and her MD from State University of New York Downstate College of Medicine in 2013. She is board certified in Preventive Medicine and completed her residency and MPH at the Icahn School of Medicine at Mt. Sinai Hospital, New York City in 2017.
At the completion of this educational session, participants will:
1. Understand STI screening and treatment updates per the 2021 Centers for Disease Control and Prevention (CDC) STI Treatment Guidelines.
2. Be able to discuss the diagnosis and management of bacterial STIs, gonorrhea, chlamydia and syphilis.
3. Know how to explain the diagnosis and management of viral STIs, anogenital herpes and human papillomavirus.
4. Appreciate the disease morbidity of extragenital STIs among people living with HIV.
This CME activity has approved for
AMA PRA Category 1.0 Credit™ for October 19, 2022, as a live activity.
This activity will also be available as an enduring activity from October 20, 2022, through October 18, 2025.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to one (1.0) Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. Braun (Course Director) has no relevant financial relationships to disclose.
- Dr. Valenti (Moderator/Panelist) has no relevant financial relationships to disclose.
- Dr. Rosalyn E. Plotzker (Presenter) has no relevant financial relationships to disclose and has submitted their slides in advance for adequate peer review and will support their presentations and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation
Download Article PDF/Slides